Dataset Information


Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson's disease models.

ABSTRACT: RNF146 is an E3 ubiquitin ligase that specifically recognizes and polyubiquitinates poly (ADP-ribose) (PAR)-conjugated substrates for proteasomal degradation. RNF146 has been shown to be neuroprotective against PAR polymerase-1 (PARP1)-induced cell death during stroke. Here we report that RNF146 expression and RNF146 inducers can prevent cell death elicited by Parkinson's disease (PD)-associated and PARP1-activating stimuli. In SH-SY5Y cells, RNF146 expression conferred resistance to toxic stimuli that lead to PARP1 activation. High-throughput screen using a luciferase construct harboring the RNF146 promoter identified liquiritigenin as an RNF146 inducer. We found that RNF146 expression by liquiritigenin was mediated by estrogen receptor activation and contributed to cytoprotective effect of liquiritigenin. Finally, RNF146 expression by liquiritigenin in mouse brains provided dopaminergic neuroprotection in a 6-hydroxydopamine PD mouse model. Given the presence of PARP1 activity and RNF146 deficits in PD, it could be a potential therapeutic strategy to restore RNF146 expression by natural compounds or estrogen receptor activation.

PROVIDER: S-EPMC5739769 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6479468 | BioStudies
| S-EPMC7909008 | BioStudies
| S-EPMC4289021 | BioStudies
| S-EPMC5337692 | BioStudies
| S-EPMC5980575 | BioStudies
| S-EPMC5490759 | BioStudies
| S-EPMC5373870 | BioStudies
2014-01-01 | S-EPMC3891871 | BioStudies
| S-EPMC7710139 | BioStudies
| S-EPMC7255037 | BioStudies